- Home
- ALEC vs MYPS Comparison
ALEC vs MYPS Comparison
Compare ALEC & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- MYPS
- Stock Information
- Founded
- ALEC 2013
- MYPS 2011
- Country
- ALEC United States
- MYPS United States
- Employees
- ALEC N/A
- MYPS N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- MYPS EDP Services
- Sector
- ALEC Health Care
- MYPS Technology
- Exchange
- ALEC Nasdaq
- MYPS Nasdaq
- Market Cap
- ALEC 124.0M
- MYPS 114.4M
- IPO Year
- ALEC 2019
- MYPS N/A
- Fundamental
- Price
- ALEC $1.27
- MYPS $0.64
- Analyst Decision
- ALEC Hold
- MYPS Buy
- Analyst Count
- ALEC 9
- MYPS 4
- Target Price
- ALEC $3.40
- MYPS $2.00
- AVG Volume (30 Days)
- ALEC 3.0M
- MYPS 267.6K
- Earning Date
- ALEC 11-06-2025
- MYPS 11-03-2025
- Dividend Yield
- ALEC N/A
- MYPS N/A
- EPS Growth
- ALEC N/A
- MYPS N/A
- EPS
- ALEC N/A
- MYPS N/A
- Revenue
- ALEC $69,048,000.00
- MYPS $247,477,000.00
- Revenue This Year
- ALEC N/A
- MYPS N/A
- Revenue Next Year
- ALEC $314.69
- MYPS N/A
- P/E Ratio
- ALEC N/A
- MYPS N/A
- Revenue Growth
- ALEC 12.26
- MYPS N/A
- 52 Week Low
- ALEC $0.87
- MYPS $0.63
- 52 Week High
- ALEC $4.18
- MYPS $2.29
- Technical
- Relative Strength Index (RSI)
- ALEC 33.72
- MYPS 21.63
- Support Level
- ALEC $1.16
- MYPS $0.70
- Resistance Level
- ALEC $1.60
- MYPS $0.82
- Average True Range (ATR)
- ALEC 0.13
- MYPS 0.05
- MACD
- ALEC 0.03
- MYPS -0.02
- Stochastic Oscillator
- ALEC 22.73
- MYPS 1.70
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.